Invasive pulmonary aspergillosis: effects of early resection in a neutropenic rat model

J M Habicht1, M Preiss, J Passweg

  • 1Division of Cardio-Thoracic Surgery, University Hospital, Basel, Switzerland. jmhabicht@intergga.ch

Abstract

Insights

Early surgical resection improved survival in rats with invasive pulmonary aspergillosis but only when not treated with amphotericin B, suggesting surgery may be beneficial in specific cases.

Area of Science:

  • Mycology and Infectious Diseases
  • Surgical Oncology
  • Pulmonology

Background:

  • Invasive pulmonary aspergillosis is a serious complication in neutropenic patients, often leading to high mortality despite antifungal therapy.
  • The potential benefit of early surgical intervention in managing localized invasive pulmonary aspergillosis remains unclear.
  • Surgery could potentially aid in diagnosis, local disease control, and prevention of systemic spread.

Purpose of the Study:

  • To investigate the impact of early surgical resection on survival rates in a rat model of localized invasive pulmonary aspergillosis.
  • To assess the effect of early resection on the dissemination of fungal disease.
  • To evaluate the combined effect of early resection and amphotericin B treatment.

Main Methods:

  • Forty neutropenic rats were inoculated with Aspergillus in the right upper lobe lung tissue.
  • Animals were divided into four groups: treated with amphotericin B (Am B) or untreated, with or without early lobectomy.
  • Survival was monitored for 28 days post-inoculation.

Main Results:

  • Early resection significantly improved survival in rats not treated with amphotericin B (50% vs. 10%).
  • In contrast, early resection did not significantly improve survival in rats treated with amphotericin B (50% vs. 70%).
  • The study demonstrated a survival benefit of early resection only in the absence of amphotericin B treatment.

Conclusions:

  • Early surgical resection can improve survival in localized invasive pulmonary aspergillosis in a rat model.
  • This survival benefit was observed exclusively in animals not receiving amphotericin B.
  • The findings suggest that adjuvant surgery may be a valuable strategy for invasive pulmonary aspergillosis in specific clinical scenarios, particularly when antifungal therapy alone is insufficient or not administered.

Related Concept Videos